CC(C)CCN1CCC[C@]2(N[C@H](c3ccc(C(F)(F)F)cc3)[C@@H]3C(=O)N(Cc4ccccc4)C(=O)[C@@H]32)C1=O.O=C(O)C(F)(F)F
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?